Treves A J, Cohen I R, Feldman M
J Natl Cancer Inst. 1975 Mar;54(3):777-80.
To learn whether tumor metastases can be prevented by the immune system, we developed a model for the treatment of mice with syngeneic lymphocytes sensitized against tumor cells in vitro. Mice were given subcutaneously tumor cells that spontaneously metastasized to the lungs. The tumors developing locally were surgically removed and the mice were inoculated with sensitized lymphocytes 1 day later. Prevention of death by lung metastases was the measure of immunotherapy. Only approximately equal to 30-40 percent of mice receiving control treatment survived, whereas approximately equal to 70 percent survived that received lymphocytes sensitized in vitro against the tumor cells. Hence sensitization of syngeneic lymphocytes against tumor cells in vitro and injection of the lymphocytes into the host after removal of a local tumor prevented the development of lethal metastases.
为了了解肿瘤转移是否能被免疫系统阻止,我们建立了一个模型,用于用体外针对肿瘤细胞致敏的同基因淋巴细胞治疗小鼠。给小鼠皮下接种会自发转移至肺部的肿瘤细胞。将局部生长的肿瘤手术切除,1天后给小鼠接种致敏淋巴细胞。以预防因肺转移导致的死亡作为免疫治疗的衡量标准。接受对照治疗的小鼠只有约30 - 40%存活,而接受体外针对肿瘤细胞致敏的淋巴细胞治疗的小鼠约70%存活。因此,体外将同基因淋巴细胞致敏于肿瘤细胞,并在切除局部肿瘤后将淋巴细胞注入宿主,可防止致死性转移的发生。